Corvus Pharmaceuticals Preferred Securities out of Shareholders Equity (Quarterly) Analysis

Corvus Pharmaceuticals, Inc. (CRVS)

18.26 +0.06 (+0.33%) USD | NASDAQ | Feb 26, 16:00

18.05 -0.21 (-1.15%) After-Hours: 07:25

View Preferred Securities out of Shareholders Equity (Quarterly) for CRVS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Securities out of Shareholders Equity (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	--
Plus Therapeutics, Inc.	--
Geron Corp.	--
Jaguar Health, Inc.	Upgrade
Krystal Biotech, Inc.	--